Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

PHASE2CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

January 31, 2007

Conditions
Attention Deficit Hyperactivity DisorderADHD
Interventions
DRUG

Modafinil

Trial Locations (18)

10010

New York University, New York

19149

CRI WorldWide, LLC, Philadelphia

21093

Adult ADD Center of Maryland, Lutherville

29407

South East Health Consultants, LLC, Charleston

32806

Clinical Neuroscience Solution, Inc., Orlando

38119

Clinical Neuroscience Solution, Memphis

40509

Michael J. Reiser, MD, LLC, Lexington

48307

Rochester Center for Behavioral Medicine, Rochester

60608

University of Illinois, Chicago

72205

Neurology Clinical Study Centers, LLC, Little Rock

90274

Peninsula Research Associates, Rolling Hills Estates

91324

Pharmacology Research Institute, Northridge

92103

UCSD Medical Center, San Diego

94549

Bay Area Research Institute, Lafayette

97210

Summit Research Network Inc., Portland

02138

Massachusetts General Hospital, Cambridge

08021

CRI WorldWide, LLC, Clementon

05091

Neuropsychiatric Associates, Woodstock

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY